Springer International Publishing Ketamine For Treatment-Resistant Depression

Name: Springer International Publishing Ketamine For Treatment-Resistant Depression
Brand: Springer International Publishing

Springer International Publishing Ketamine For Treatment-Resistant Depression thumbnail

Preisalarm

★ 4.9

95,74 €

Bester Preis bei medimops.de

Preisalarm

★ 4.9

95,74 €

Bester Preis bei medimops.de

Preisalarm

★ 4.9

95,74 €

Bester Preis bei medimops.de

Preisdetails

Der niedrigste Preis für ein neues Springer International Publishing Ketamine For Treatment-Resistant Depression beträgt 95,74 €. Dies ist derzeit das günstigste Angebot aus 2 Shops.

Produktinformationen

This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic moleculartargets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.

Bewertungen

0,0

Noch keine Bewertungen

Seien Sie der Erste, der seine Erfahrung mit diesem Produkt teilt!

Das könnte Ihnen auch gefallen

Wir konnten derzeit keine vorgeschlagenen Produkte finden.

Shops, die dieses Produkt verkaufen

Produktinformationen

Springer International Publishing Ketamine For Treatment-Resistant Depression

Preisdetails

Produktinformationen

Bewertungen

Das könnte Ihnen auch gefallen

Shops, die dieses Produkt verkaufen

Abonnieren Sie unseren Newsletter

PriceRadar

Produktinformationen

Bewertungen

Das könnte Ihnen auch gefallen